Skip to main content
. 2019 Sep 17;20(18):4592. doi: 10.3390/ijms20184592

Figure 4.

Figure 4

Janus-faced cardiovascular consequences of AGXT2 upregulation. Therapeutic upregulation of AGXT2 may exert a positive effect on cardiovascular system via lowering of ADMA and SDMA. However, there may also be a possible harmful effect caused by lowering of homoarginine, BAIBA and β-alanine levels.